Filing Details
- Accession Number:
- 0001415889-25-005369
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-24 20:00:44
- Reporting Period:
- 2025-02-24
- Filing Date:
- 2025-02-24
- Accepted Time:
- 2025-02-24 20:00:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1786205 | Arcellx Inc. | ACLX | Biological Products, (No Disgnostic Substances) (2836) | 472855917 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789632 | Christopher Heery | C/O Arcellx, Inc. 800 Bridge Parkway Redwood City CA 94065 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-07 | 22,556 | $0.00 | 47,641 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-24 | 4,370 | $63.14 | 43,271 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-24 | 5,577 | $64.26 | 37,694 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-24 | 208 | $64.88 | 37,486 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2025-02-07 | 22,556 | $0.00 | 22,556 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Vesting of these RSUs previously reported in the Form 4 filed February 11, 2025.
- Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- Represents the weighted average share price of an aggregate total of 4,370 shares sold in the price range of $62.79 to $63.775 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 5,577 shares sold in the price range of $63.825 to $64.805 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 208 shares sold in the price range of $64.845 to $64.89 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the RSUs subject to the award will vest each year following the RSU Grant Date on the same day of the month as the RSU Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "RSU Grant Date" shall mean February 7, 2022.
Billionaire Hedge Funds
